ZYNTEMA Trademark

Trademark Overview

On Tuesday, December 29, 2009, a trademark application was filed for ZYNTEMA with the United States Patent and Trademark Office. The USPTO has given the ZYNTEMA trademark a serial number of 79079727. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, December 29, 2019. This trademark is owned by Novartis AG. The ZYNTEMA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; vaccines; diagnostic preparations for medical use; excluding ophthalmic preparations
zyntema

General Information

Serial Number79079727
Word MarkZYNTEMA
Filing DateTuesday, December 29, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, December 29, 2019
Registration Number4004453
Registration DateTuesday, August 2, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2011

Trademark Statements

Goods and ServicesAnti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; vaccines; diagnostic preparations for medical use; excluding ophthalmic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, July 12, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Saturday, January 16, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, January 16, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, September 21, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 17, 2018NOTIFICATION PROCESSED BY IB
Friday, July 28, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, July 28, 2017DEATH OF INTERNATIONAL REGISTRATION
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, January 13, 2012FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 13, 2012FINAL DISPOSITION PROCESSED
Wednesday, November 2, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 2, 2011REGISTERED-PRINCIPAL REGISTER
Monday, June 27, 2011NOTIFICATION PROCESSED BY IB
Tuesday, May 17, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2011PUBLISHED FOR OPPOSITION
Wednesday, April 27, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 27, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, April 8, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 8, 2011ASSIGNED TO LIE
Friday, March 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 25, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 25, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 25, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 27, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 27, 2010NON-FINAL ACTION E-MAILED
Monday, December 27, 2010NON-FINAL ACTION WRITTEN
Wednesday, November 24, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 24, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 24, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 24, 2010PETITION TO REVIVE-GRANTED
Wednesday, November 24, 2010TEAS PETITION TO REVIVE RECEIVED
Monday, November 22, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 22, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 5, 2010ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 5, 2010ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 7, 2010REFUSAL PROCESSED BY IB
Monday, March 29, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 29, 2010REFUSAL PROCESSED BY MPU
Saturday, March 27, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 26, 2010NON-FINAL ACTION WRITTEN
Thursday, March 25, 2010ASSIGNED TO EXAMINER
Tuesday, March 23, 2010APPLICATION FILING RECEIPT MAILED
Friday, March 19, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 18, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zyntema system disorders preparations treatment diseases prevention pharmaceutical based tissue organ